| Home : Adaptive Servo-ventilation (ASV) Therapy Suggests Positive Cardiovascular Outcomes for People with Sleep-Disordered Breathing and Heart Failure With Preserved Ejection Fraction In Phase II Study |
|
May 22
2016 |
Adaptive Servo-ventilation (ASV) Therapy Suggests Positive Cardiovascular Outcomes for People with Sleep-Disordered Breathing and Heart Failure With Preserved Ejection Fraction In Phase II Study |
|
FLORENCE, Italy, May 22, 2016 /PRNewswire/-- ResMed (NYSE: RMD) today announced primary results from a multicenter, randomized controlled Phase II trial known as CAT-HF presented at the European Society of Cardiology's 2016 Annual Heart Failure Congress. CAT-HF assessed whether the... |
|
|
|
| Source:http://www.prnewswire.com/news-releases/adaptive-servo-ventilation-asv-therapy-suggests-positive-cardiovascular-outcomes-for-people-with-sleep-disordered-breathing-and-heart-failure-with-preserved-ejection-fraction-in-phase-ii-study-300272791.html |
| |
|
Related News
|
» Dodson Norwood Establishes Research Team for Sustainable Investing
» U.S. Census Bureau Daily Feature for May 22: Digitalization
|
